References
- DociRGennariLBignamiPMorbidity and mortality after hepatic resection of metastases from colorectal cancerBr J Surg1995823773817796016
- BarnettIvan SluijsEMFOgilvieDPhysical activity and transitioning to retirementAm J Prev Med20124332933622898127
- NordlingerBVan CutsemEGruenbergerTCombination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelAnn Oncol20092098599219153115
- HåkanssonLHåkanssonAMoralesOThoreliusLWarfvingTSpherex (degradable starch microspheres) chemo-occlusion – enhancement of tumor drug concentration and therapeutic efficacy: an overviewSemin Oncol199724S6-100S6-109
- MinochaJLewandowskiRJAssessing imaging response to therapyRadiol Clin North Am2015531077108826321455
- KimMNKimBKHanKHKimSUEvolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessmentExpert Rev Gastroenterol Hepatol2015933534825370168
- LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis201030526020175033
- VoglTJZangosSEichlerKColorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an updateEur Radiol2007171025103416944163
- GermerCTBuhrHJIsbertCMöglichkeiten und Grenzen der Ablationsverfahren zur Behandlung von Lebermetastasen unter kurativer Intention. [Nonoperative ablation for liver metastases. Possibilities and limitations as a curative treatment]Chir Z Alle Geb Oper Medizen200576552554556563 German
- BreedisCYoungGThe blood supply of neoplasms in the liverAm J Pathol19543096997713197542
- AlbertsSRUpdate on the optimal management of patients with colorectal liver metastasesCrit Rev Oncol Hematol201284597022425016
- NishiofukuHTanakaTMatsuokaMTranscatheter arterial chemoembolization using cisplatin powder mixed with degradable starch microspheres for colorectal liver metastases after FOLFOX failure: results of a phase I/II studyJ Vasc Interv Radiol201324566523194749
- TsuchiyaMWatanabeMOtsukaYTransarterial chemoembolization with irinotecan (CPT-11) and degradable starch microspheres (DSM) in patients with liver metastases from colorectal cancerGan To Kagaku Ryoho20073420382040 Japanese18219891
- WasserKGiebelFFischbachRTransarterielle Chemoembolisation von Lebermetastasen kolorektaler Karzinome mit abbaubaren Stärkepartikeln (Spherex®). [Transarterial chemoembolization of liver metastases of colorectal carcinoma using degradable starch microspheres (Spherex®): personal investigations and review of the literature]Radiol200545633643
- HeskethPJChemotherapy-induced nausea and vomitingN Engl J Med20083582482249418525044
- NavariRMAaproMAntiemetic prophylaxis for chemotherapy-induced nausea and vomitingN Engl J Med20163741356136727050207
- WeitzJKochMDebusJColorectal cancerLancet Lond Engl2005365153165
- WollnerISWalker-AndrewsSCSmithJEEnsmingerWDPhase II study of hepatic arterial degradable starch microspheres and mitomycinCancer Drug Deliv198632792843105862
- LorenzMHerrmannGKirkowa-ReimannMTemporary chemoembolization of colorectal liver metastases with degradable starch microspheresEur J Surg Oncol1989154534622792397
- TaguchiTOgawaNBunkeBThe use of degradable starch microspheres (Spherex) with intra-arterial chemotherapy for the treatment of primary and secondary liver tumours – results of a phase III clinical trialReg Cancer Treat19924161165
- FujimotoSKoikeSTakahashiMIntra-arterial infusion chemotherapy with degradable starch microspheres and mitomycin C for unresectable hepatic metastasis from gastrointestinal cancerReg Cancer Treat19931711
- CivalleriDPectorJCHåkanssonLArnaudJPDuezNBuyseMTreatment of patients with irresectable liver metastases from colorectal cancer by chemo-occlusion with degradable starch microspheresBr J Surg199481133813417953406
- VoigtWBehrmannCSchlueterAA new chemoembolization protocol in refractory liver metastasis of colorectal cancer – a feasibility studyOnkologie20022515816412006767